Sugi Predict

Sugi Predict / Targets / PFDN6

PFDN6

Prefoldin subunit 6 · O15212 · PFDN6 on Sugi Atlas →

0 patent compounds predicted against PFDN6, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to PFDN6 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Ketamine Treatment Effects on Synaptic Plasticity in Depression PHASE4COMPLETED
Treatment of Ectopic Calcification in Fahr's Disease or Syndrome PHASE2RECRUITING
Targeting Endoplasmic Reticulum Stress in Human Hypertension PHASE1/PHASE2RECRUITING
A Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of BBM-D101 in the Treatment of Duchenne Muscular Dystrophy. PHASE1/PHASE2RECRUITING
Safety and Pharmacology of SNX-5422 Plus Carboplatin and Paclitaxel in Subjects With Solid Tumors PHASE1COMPLETED
Study of Oral CNF2024 (BIIB021) in Advanced Solid Tumors PHASE1COMPLETED
Dynamics of Muscle Mitochondria in Type 2 Diabetes (DYNAMMO T2D) EARLY_PHASE1COMPLETED
Evaluation of the Safety and Efficacy of BBM-D101 to Treat Patients with Duchenne Muscular Dystrophy EARLY_PHASE1RECRUITING
Investigations Into ISCU Myopathy or Iron Sulfur Scaffold U Protein Myopathy nanCOMPLETED
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Gene Analysis of Parkinson's Disease nanCOMPLETED
Measuring Protein Turnover in Humans Across the Lifespan by Metabolic Labeling With Deuterium Oxide nanRECRUITING
C-Protein in Fatigue and Aging nanRECRUITING
Muscle Tissue Bank for Muscular Dystrophy nanCOMPLETED
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Registry and Natural History Study for Early Onset Hereditary Spastic Paraplegia nanRECRUITING
Mapping Novel Disease Genes for Dilated Cardiomyopathy nanCOMPLETED
Whole Genome Scan of Extended Families With Familial Vocal Cord Paralysis nanCOMPLETED
Role of Sorcin and Annexin A3 in Breast Cancer Patients nanUNKNOWN
Identification of New FTLD Genes nanUNKNOWN
Natural History Study of FDXR Mutation-related Mitochondriopathy nanCOMPLETED
Autophagy Bladder Cancer nanUNKNOWN
Natural History of Neuronal Ceroid Lipofuscinosis, Batten's CLN6 Diseae nanACTIVE_NOT_RECRUITING
Implementation of Molecular Diagnostic Pathways nanUNKNOWN
Hereditary Spastic Paraplegia Genomic Sequencing Initiative (HSPseq) nanRECRUITING
Genetic Analysis of Hereditary Disorders of Hearing and Balance nanCOMPLETED
Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH) nanCOMPLETED
Dynamics of Muscle Mitochondria in Type 2 Diabetes Exercise nanCOMPLETED
Familial Partial Lipodystrophy Study nanCOMPLETED
Genetic Analysis of Heart Channelopathies in Brazilian Patients and Their Relatives nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a PFDN6 binder may also engage these)

ProteinNameSimilarity
Q17Q89 — 1.000 Q17Q89 →
Q03958 — 1.000 Q03958 →
Q5TJE6 — 1.000 Q5TJE6 →
P52554 — 0.995 P52554 →
Q2HIK4 — 0.994 Q2HIK4 →
A8Y197 — 0.991 A8Y197 →
O14450 — 0.987 O14450 →
Q9VW56 — 0.984 Q9VW56 →
P52553 — 0.984 P52553 →
Q9VTE5 — 0.982 Q9VTE5 →
Q54M71 — 0.978 Q54M71 →
Q9LJ98 — 0.977 Q9LJ98 →
Q9N5M2 — 0.977 Q9N5M2 →
O14334 — 0.976 O14334 →
Q61SU8 — 0.975 Q61SU8 →
A8WVJ9 — 0.975 A8WVJ9 →
Q04493 — 0.975 Q04493 →
Q8I3Y6 — 0.975 Q8I3Y6 →
O94307 — 0.975 O94307 →
Q9UTC9 — 0.974 Q9UTC9 →
P40005 — 0.973 P40005 →
Q94AF7 — 0.973 Q94AF7 →
B8GDQ7 — 0.972 B8GDQ7 →
Q17827 — 0.972 Q17827 →
Q54V55 — 0.971 Q54V55 →
A3CW49 — 0.970 A3CW49 →
A8XPL7 — 0.970 A8XPL7 →
O18054 — 0.969 O18054 →
Q21993 — 0.969 Q21993 →
Q9VCZ8 — 0.969 Q9VCZ8 →